SHAREHOLDER ALERT: Tripp Levy PLLC Notifies Investors of Class Action Against PetMed Express, Inc. (PETS) & Lead Plaintiff – Deadline: October 24, 2017

August 29, 2017
New York, New York

Tripp Levy PLLC notifies investors that a class action lawsuit has been filed against PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) and certain of its officers on behalf of a class consisting of investors who purchased PetMed securities between May 8, 2017 through August 23, 2017, both dates inclusive (the “Class Period”).

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) PetMed was marketing dangerous and addictive animal drugs to humans; (2) as such, PetMed is vulnerable to potential civil or criminal liability, as well as other regulatory action; (3) in turn, Google may halt PetMed’s advertising activities; and (4) consequently, defendants’ statements about PetMed’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

On August 23, 2017, Aurelius Value published an article alleging that PetMed targets opioid users with Google ads and other marketing techniques aimed at facilitating the abuse of opioids. Following this news, PetMed stock dropped.

Please contact us toll free at 1-800-906-6432 or contact us via our website with any questions regarding your rights to recover your losses at no cost or expense.

Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and has assisted in the recovery of billions of dollars for shareholders in securities actions around the globe.

Attorney advertising. Prior results do not indicate a similar outcome.